Published in J Am Geriatr Soc on July 01, 1984
The economic costs of Alzheimer's disease. Am J Public Health (1987) 1.69
Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. Ann Indian Acad Neurol (2014) 1.09
Differential diagnosis of dementia. Br Med J (Clin Res Ed) (1986) 0.90
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet (2000) 7.31
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet (1992) 4.31
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol (1999) 3.62
Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol (2001) 3.19
Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology (2007) 2.72
Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci (1997) 2.59
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol (2000) 2.37
The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc (2001) 2.30
Education and dementia: what lies behind the association? Neurology (2007) 2.26
Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ (1996) 2.20
Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology (1997) 2.14
Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology (2004) 2.10
Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol (1999) 2.08
An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord (2006) 2.08
Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology (1991) 2.05
Major depression in stroke patients. A 3-year longitudinal study. Stroke (1993) 2.04
Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites. II. Assessment of human brain and cerebrospinal fluid concentrations. J Chromatogr (1987) 2.04
Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology (2001) 2.04
Scanning electron microscopic study of virulent and avirulent colonies of Neisseria gonorrhoeae. Infect Immun (1975) 2.03
Relationship between prophylactic effect of lithium therapy and family history of affective disorders. Biol Psychiatry (1997) 2.03
Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J Comp Neurol (1997) 1.99
Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J (2001) 1.97
Acute confusional states in elderly patients treated for femoral neck fracture. J Am Geriatr Soc (1988) 1.95
Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci U S A (1994) 1.91
Power of selective genotyping in genetic association analyses of quantitative traits. Behav Genet (2000) 1.89
Defective brain microtubule assembly in Alzheimer's disease. Lancet (1986) 1.89
Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology (2010) 1.88
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. J Neurol Neurosurg Psychiatry (1998) 1.83
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology (2007) 1.81
Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology (1999) 1.78
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J Intern Med (2014) 1.75
Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry (1979) 1.71
Distribution of different fiber types in human skeletal muscles: effects of aging studied in whole muscle cross sections. Muscle Nerve (1983) 1.70
The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology (1999) 1.67
Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. Neurology (2010) 1.67
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport (2001) 1.63
APOE influences on neuropsychological function after mild head injury: within-person comparisons. Neurology (2004) 1.58
The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med (2009) 1.57
Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 1.55
Underdiagnosis and poor documentation of acute confusional states in elderly hip fracture patients. J Am Geriatr Soc (1991) 1.55
Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology (1992) 1.54
Heart failure and Alzheimer's disease. J Intern Med (2014) 1.54
Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. J Clin Epidemiol (2001) 1.54
Costs of dementia and dementia care: a review. Int J Geriatr Psychiatry (1997) 1.52
Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. Am J Public Health (1998) 1.51
Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol (1999) 1.50
A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. Am J Hum Genet (2001) 1.49
Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging (2000) 1.49
Postoperative confusion after anesthesia in elderly patients with femoral neck fractures. Anesth Analg (1987) 1.48
Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia (1996) 1.47
Clinical trials in mild cognitive impairment: lessons for the future. J Neurol Neurosurg Psychiatry (2005) 1.47
Clinical profile of delirium in older patients. J Am Geriatr Soc (1999) 1.46
Preclinical symptoms of major depression in very old age: a prospective longitudinal study. Am J Psychiatry (1998) 1.43
Treatment of Alzheimer disease with tacrine: a cost-analysis model. Alzheimer Dis Assoc Disord (1997) 1.42
Growth pattern and cell division in Neisseria gonorrhoeae. J Bacteriol (1977) 1.40
PMP22 Thr(118)Met: recessive CMT1 mutation or polymorphism? Nat Genet (1997) 1.39
The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project. Arch Neurol (2001) 1.38
Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology (2006) 1.38
Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol (1999) 1.38
Elevated cortical zinc in Alzheimer disease. Neurology (2006) 1.38
Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett (2000) 1.37
[More accurate diagnosis could identify patients suitable for tacrine therapy]. Lakartidningen (1996) 1.37
Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin Neurophysiol (2000) 1.37
Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment. Neurosci Lett (1999) 1.32
Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U S A (1994) 1.31
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Ann Neurol (1993) 1.29
Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia (2009) 1.29
Geriatric-based versus general wards for older acute medical patients: a randomized comparison of outcomes and use of resources. J Am Geriatr Soc (2000) 1.29
Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry (2008) 1.28
A geriatric-anesthesiologic program to reduce acute confusional states in elderly patients treated for femoral neck fractures. J Am Geriatr Soc (1991) 1.27
Accuracy of the Mini-Mental Status Examination as a screening test for dementia in a Swedish elderly population. Acta Neurol Scand (1993) 1.25
Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neurosci Lett (1992) 1.25
Altered deactivation in individuals with genetic risk for Alzheimer's disease. Neuropsychologia (2008) 1.25
Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J Neurol Neurosurg Psychiatry (2004) 1.25
No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Arch Neurol (1997) 1.25
Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study. Neurology (2008) 1.24
Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study. Am J Epidemiol (1999) 1.24
Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res (1998) 1.23
Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol (1999) 1.23
Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry (2001) 1.23
Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (1987) 1.22
The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J Neural Transm (1985) 1.21
Pathways to Alzheimer's disease. J Intern Med (2014) 1.20
Environmental enrichment and the brain. Prog Brain Res (2002) 1.20
Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm (1976) 1.18
Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol (1998) 1.18
Falls leading to femoral neck fractures in lucid older people. J Am Geriatr Soc (1996) 1.17
The antidepressant and antiinflammatory effects of rolipram in the central nervous system. CNS Drug Rev (2001) 1.17
Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc (1998) 1.17
Sleep apnea, delirium, depressed mood, cognition, and ADL ability after stroke. J Am Geriatr Soc (2001) 1.15
Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and homovanillic acid in brain tissue from an autopsy material. Acta Psychiatr Scand (1974) 1.14